Diffusing capacity in patients with different pulmonary disorders Source: Eur Respir J 2003; 22: Suppl. 45, 146s Year: 2003
Is pulmonary hypertension in intermedia beta-thalassemia patients related to pulmonary ventilatory dysfunction? Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009
Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015
Reduced exercise capacity and impaired pulmonary function in patients with scleroderma Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
Pulmonary fuction and exercise capacity evaluation in adult thalassemic patients Source: Eur Respir J 2006; 28: Suppl. 50, 708s Year: 2006
The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021
Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018
More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017 Year: 2017
Pulmonary function and functional capacity in survivors of severe acute respiratory syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004
Pulmonary function abnormalities in Egyptian sickle cell disease patients Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011
Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Influence of critical hyperinflation in exercise capacity improvement after pulmonary rehabilitation in severely obstructed patients Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016
Pulmonary rehabilitation in patients with pulmonary sarcoidosis: impact on exercise capacity and fatigue. Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1 Year: 2020
Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
Emphysema and carbonmonoxide diffusion capacity in male chronic obstructive pulmonary disease patients Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution Year: 2009
Diffusing capacity and lung circulation in chronic obstructive pulmonary disease with different degrees of respiratory failure Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (2) 1702593; 10.1183/13993003.02593-2017 Year: 2018
Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010